mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
Metadatos
Mostrar el registro completo del ítemAutor
Sánchez Medina, María Pilar; Serrano Falcón, Cristina; Martínez Rodríguez, Sergio; Torres De Pinedo, Jesús Manuel; Serrano Ortega, Salvio; Ortega Sánchez, EsperanzaEditorial
MDPI
Materia
Androgenic alopecia Aromatase 5α-R isozymes
Fecha
2023-12-14Referencia bibliográfica
Sánchez, P.; Serrano Falcón, C.; Martínez Rodríguez, S.; Torres, J.M.; Serrano, S.; Ortega, E. mRNA Levels of Aromatase, 5 -Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia. Int. J. Mol. Sci. 2023, 24, 17461. https://doi.org/10.3390/ijms242417461
Patrocinador
Andalusian Regional Government (CTS-202 Endocrinology and Metabolism Group)Resumen
Androgenic alopecia (AGA) is the most prevalent type of progressive hair loss and has psychological repercussions. Nevertheless, the effectiveness of current pharmacological treatments remains limited, in part because the molecular basis of the disease has not been fully elucidated. Our group previously highlighted the important roles of aromatase and 5α-reductase (5α-R) in alopecia in young women with female pattern hair loss. Additionally, an association has been proposed between AGA and prostate cancer (PCa), suggesting that genes implicated in PCa would also be involved in AGA. A low-invasive, sensitive, and precise method was used to determine mRNA levels of aromatase, 5α-R isozymes, and 84 PCa-related genes in samples of plucked hair from young men with AGA and controls. Samples were obtained with a trichogram from the vertex scalp, and mRNA levels were quantified using real-time RT-PCR. The men with AGA had significantly higher 5α-R2 mRNA levels in comparison to controls; interestingly, some of them also showed markedly elevated mRNA levels of 5α-R1 or 5α-R3 or of both, which may explain the varied response to 5α-R inhibitor treatments. The men with AGA also showed significant changes versus controls in 6 out of the 84 genes implicated in PCa. This study contributes greater knowledge of the molecular bases of AGA, facilitating early selection of the most appropriate pharmacological therapy and opening the way to novel treatments.